Genetic testing for inherited ocular disease: Delivering on the promise at last?

Rachel L. Gillespie, Georgina Hall, Graeme C. Black

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Genetic testing is of increasing clinical utility for diagnosing inherited eye disease. Clarifying a clinical diagnosis is important for accurate estimation of prognosis, facilitating genetic counselling and management of families, and in the future will direct gene-specific therapeutic strategies. Often, precise diagnosis of genetic ophthalmic conditions is complicated by genetic heterogeneity, a difficulty that the so-called 'next-generation sequencing' technologies promise to overcome. Despite considerable counselling and ethical complexities, next-generation sequencing offers to revolutionize clinical practice. This will necessitate considerable adjustment to standard practice but has the power to deliver a personalized approach to genomic medicine for many more patients and enhance the potential for preventing vision loss. © 2013 Royal Australian and New Zealand College of Ophthalmologists.
    Original languageEnglish
    Pages (from-to)65-77
    Number of pages12
    JournalClinical and Experimental Ophthalmology
    Volume42
    Issue number1
    DOIs
    Publication statusPublished - Jan 2014

    Keywords

    • Counselling
    • Ethics
    • Genetics
    • Inherited eye disease
    • Testing

    Fingerprint

    Dive into the research topics of 'Genetic testing for inherited ocular disease: Delivering on the promise at last?'. Together they form a unique fingerprint.

    Cite this